ZETA|Facility Types & Modalities|Monoclonal Antibodies (mAbs)
From to ZETA
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Manufacturing for Monoclonal Antibodies

ZETA delivers end-to-end, GMP-compliant solutions for scalable, high-yield mAb manufacturing.

Monoclonal antibodies (mAbs) are transforming medicine – and demand is rising.
Person with tablet operating a small control screen in front of a production skid
Caption: Lorem ipsum dolor sit amet, consectetuer
Person with lab coat, face mask and protective gloves handling a device in front of a manufacturing skid

From immunology to oncology. Meeting growing demand with scalable systems.

Monoclonal antibodies have transformed treatment in oncology, immunology, and beyond – but delivering them at scale demands process precision, robust quality systems, and strict regulatory adherence. ZETA supports manufacturers with complete mAb production solutions, from cell culture to final purification, enabling safe, high-yield, and GMP-compliant manufacturing.

Tackling the challenges of mAb manufacturing. Building achievements on strong foundations.

Downstream processing

Achieve high product purity with efficient chromatography and filtration strategies.

Regulatory compliance

Comply with evolving GMP standards for both clinical and commercial supply.

Scale-up

Ensure performance consistency across lab, pilot, and industrial-scale production.

Time

Accelerate time to clinic with high-titer cell lines.

Yield optimization

Achieving high yields while minimizing by-products.

From upstream to downstream. Reducing risks. Improving efficiency.

ZETA delivers fully integrated systems covering media preparation, cell culture, harvesting, purification, and formulation. Our experience with high-value biologics – combined with automation, single-use, and stainless-steel technologies – ensures scalable solutions that reduce risk, improve efficiency, and accelerate time to market for monoclonal antibodies.

Super skid with large production vessels

Upstream, Harvest and Downstream Biopharma Production

Complex mAb Project realized efficiently.

Flexible multiproduct facility for monoclonal antibodies delivered on fast-track schedule. End-to-end upstream and downstream integration enables scalable CHO-based biomanufacturing with future-ready process adaptability.

Looking for scalable, compliant mAb manufacturing expertise?

Johannes Koch
Director Business Line Engineering & Services
Portrait picture of a person wearing a white shirt and a black blazer in front of a light background.
I would like to receive regular information and electronic advertising and agree that my data may be processed and used for this purpose by all companies of the ZETA Group worldwide.
zeta.com is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us. By submitting, I agree to the Terms of Use and the Privacy Policy.
>

Please complete the form to receive the requested content.

zeta.com is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us. By submitting, I agree to the Terms of Use and the Privacy Policy.

Show content